Cargando…
A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis
Toxoplasma gondii is an apicomplexan pathogen infecting 2 billion people and numerous livestock, causing a major threat to economies and human health. Passive-active immunoprophylaxis is an efficient approach to provide protection against toxoplasmosis. T. gondii perforin-like protein 2 (TgPLP2) con...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890382/ https://www.ncbi.nlm.nih.gov/pubmed/35252413 http://dx.doi.org/10.3389/fvets.2021.802250 |
_version_ | 1784661623948967936 |
---|---|
author | Tian, Xiaowei Sun, Hanqi Wang, Meng Wan, Guangmin Xie, Tong Mei, Xuefang Zhang, Zhenchao Li, Xiangrui Wang, Shuai |
author_facet | Tian, Xiaowei Sun, Hanqi Wang, Meng Wan, Guangmin Xie, Tong Mei, Xuefang Zhang, Zhenchao Li, Xiangrui Wang, Shuai |
author_sort | Tian, Xiaowei |
collection | PubMed |
description | Toxoplasma gondii is an apicomplexan pathogen infecting 2 billion people and numerous livestock, causing a major threat to economies and human health. Passive-active immunoprophylaxis is an efficient approach to provide protection against toxoplasmosis. T. gondii perforin-like protein 2 (TgPLP2) contains a membrane attack complex/perforin (MACPF) domain, making it a potential vaccine candidate. Here, we aimed to assess the protection efficacy of TgPLP2 using Bagg albino/c (BALB/c) mice model. The Escherichia coli system was used to obtain the recombinant TgPLP2 (rTgPLP2). Mice challenged by anti-rTgPLP2 polyclonal antibodies (PcAb) pretreated tachyzoites showed obviously increased survival outcomes. In addition, mice that passively received anti-rTgPLP2 PcAb following a lethal dose of tachyzoites infection had longer survival time compared with phosphate-buffered saline (PBS) controls. Furthermore, we demonstrated that immunization with rTgPLP2 could prolong survival in RH strain infected mice and resulted in the lowest brain cysts size and number of Prugniaud (PRU) genotype II strain infected mice. High levels of Toxoplasma-specific IgG, IgG1, IgG2a, and cytokines (IFN-γ and IL-10) were produced after two immunizations with rTgPLP2. Together these results indicated that TgPLP2 can induce both humoral and cellular immune responses to protect host against infection and thus is a potential candidate for T. gondii vaccines. |
format | Online Article Text |
id | pubmed-8890382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88903822022-03-03 A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis Tian, Xiaowei Sun, Hanqi Wang, Meng Wan, Guangmin Xie, Tong Mei, Xuefang Zhang, Zhenchao Li, Xiangrui Wang, Shuai Front Vet Sci Veterinary Science Toxoplasma gondii is an apicomplexan pathogen infecting 2 billion people and numerous livestock, causing a major threat to economies and human health. Passive-active immunoprophylaxis is an efficient approach to provide protection against toxoplasmosis. T. gondii perforin-like protein 2 (TgPLP2) contains a membrane attack complex/perforin (MACPF) domain, making it a potential vaccine candidate. Here, we aimed to assess the protection efficacy of TgPLP2 using Bagg albino/c (BALB/c) mice model. The Escherichia coli system was used to obtain the recombinant TgPLP2 (rTgPLP2). Mice challenged by anti-rTgPLP2 polyclonal antibodies (PcAb) pretreated tachyzoites showed obviously increased survival outcomes. In addition, mice that passively received anti-rTgPLP2 PcAb following a lethal dose of tachyzoites infection had longer survival time compared with phosphate-buffered saline (PBS) controls. Furthermore, we demonstrated that immunization with rTgPLP2 could prolong survival in RH strain infected mice and resulted in the lowest brain cysts size and number of Prugniaud (PRU) genotype II strain infected mice. High levels of Toxoplasma-specific IgG, IgG1, IgG2a, and cytokines (IFN-γ and IL-10) were produced after two immunizations with rTgPLP2. Together these results indicated that TgPLP2 can induce both humoral and cellular immune responses to protect host against infection and thus is a potential candidate for T. gondii vaccines. Frontiers Media S.A. 2022-02-15 /pmc/articles/PMC8890382/ /pubmed/35252413 http://dx.doi.org/10.3389/fvets.2021.802250 Text en Copyright © 2022 Tian, Sun, Wang, Wan, Xie, Mei, Zhang, Li and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Tian, Xiaowei Sun, Hanqi Wang, Meng Wan, Guangmin Xie, Tong Mei, Xuefang Zhang, Zhenchao Li, Xiangrui Wang, Shuai A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis |
title | A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis |
title_full | A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis |
title_fullStr | A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis |
title_full_unstemmed | A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis |
title_short | A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis |
title_sort | novel vaccine candidate: recombinant toxoplasma gondii perforin-like protein 2 stimulates partial protective immunity against toxoplasmosis |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890382/ https://www.ncbi.nlm.nih.gov/pubmed/35252413 http://dx.doi.org/10.3389/fvets.2021.802250 |
work_keys_str_mv | AT tianxiaowei anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT sunhanqi anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT wangmeng anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT wanguangmin anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT xietong anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT meixuefang anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT zhangzhenchao anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT lixiangrui anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT wangshuai anovelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT tianxiaowei novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT sunhanqi novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT wangmeng novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT wanguangmin novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT xietong novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT meixuefang novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT zhangzhenchao novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT lixiangrui novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis AT wangshuai novelvaccinecandidaterecombinanttoxoplasmagondiiperforinlikeprotein2stimulatespartialprotectiveimmunityagainsttoxoplasmosis |